Gillinov A M, Zehr K J, Redmond J M, Gott V L, Deitz H C, Reitz B A, Laschinger J C, Cameron D E
Division of Cardiac Surgery and Center for Medical Genetics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
Ann Thorac Surg. 1997 Oct;64(4):1140-4; discussion 1144-5. doi: 10.1016/s0003-4975(97)00849-7.
The development of new screening techniques for the early detection of Marfan's syndrome has prompted evaluation of the results of cardiac operations in children with this syndrome. The purpose of this study was to determine the surgical indications, operative results, and need for reoperation in children with Marfan's syndrome.
From 1980 to 1996, 245 patients underwent cardiac operations for complications of Marfan's syndrome; 26 (11%) were less than 18 years of age. The mean age at the time of operation was 10.3 +/- 1 years (range, 8 months to 17 years); 18 of the patients were male. Indications for operation were aortic root dilatation (15 patients), mitral regurgitation (4 patients), aortic root dilatation and mitral regurgitation (6 patients), and aortic arch aneurysm (1 patient). Operations included aortic root replacement (15 patients), aortic root replacement and mitral repair (5 patients), aortic root replacement and mitral replacement (1 patient), mitral repair (3 patients), mitral replacement (1 patient), and arch aneurysm repair (1 patient). The mean aortic root diameter in patients undergoing aortic root replacement was 6.2 +/- 0.2 cm. Only 1 patient underwent ascending aortic dissection. RESULTS. There were no operative deaths. At a mean follow-up of 67.1 +/- 10.2 months, 8 patients required a second cardiac procedure (41% +/- 17% 10-year freedom from reoperation). Indications for further operations were distal aortic pathology (3 patients), aortic root dilatation after initial mitral operation (3 patients), failed mitral repair (1 patient), and homograft degeneration (1 patient). Risk factors for a second cardiac procedure were age less than 10 years at the time of the first operation (p < 0.003) and mitral regurgitation (p < 0.04). Overall, 25 (96%) of 26 patients have undergone aortic root replacement and 11 (42%) patients have undergone a mitral procedure. There have been 4 late deaths, all of presumed cardiac origin. The 10-year survival rate is 79% +/- 10%. All surviving patients are in New York Heart Association functional class I or II.
We conclude that (1) aortic root dilatation is the most common surgical indication in children with Marfan's syndrome, (2) mitral regurgitation is the second most common indication, (3) aortic dissection is unusual in children with Marfan's syndrome, and (4) careful follow-up is necessary, particularly in younger children, because more than half of all children with Marfan's syndrome require repeated cardiac operations within 10 years.
用于早期检测马方综合征的新筛查技术的发展促使人们对患有该综合征儿童的心脏手术结果进行评估。本研究的目的是确定马方综合征患儿的手术指征、手术结果以及再次手术的必要性。
1980年至1996年期间,245例患者因马方综合征并发症接受了心脏手术;其中26例(11%)年龄小于18岁。手术时的平均年龄为10.3±1岁(范围为8个月至17岁);18例患者为男性。手术指征包括主动脉根部扩张(15例患者)、二尖瓣反流(4例患者)、主动脉根部扩张合并二尖瓣反流(6例患者)以及主动脉弓动脉瘤(1例患者)。手术包括主动脉根部置换(15例患者)、主动脉根部置换加二尖瓣修复(5例患者)、主动脉根部置换加二尖瓣置换(1例患者)、二尖瓣修复(3例患者)、二尖瓣置换(1例患者)以及主动脉弓动脉瘤修复(1例患者)。接受主动脉根部置换患者的平均主动脉根部直径为6.2±0.2厘米。仅1例患者发生升主动脉夹层。结果。无手术死亡病例。平均随访67.1±10.2个月时,8例患者需要进行第二次心脏手术(10年免于再次手术率为41%±17%)。进一步手术指征为主动脉远端病变(3例患者)、初次二尖瓣手术后主动脉根部扩张(3例患者)、二尖瓣修复失败(1例患者)以及同种异体移植物退变(1例患者)。第二次心脏手术的危险因素为首次手术时年龄小于10岁(p<0.003)以及二尖瓣反流(p<0.04)。总体而言,26例患者中有25例(96%)接受了主动脉根部置换,11例(42%)患者接受了二尖瓣手术。有4例晚期死亡病例,均推测为心脏原因。10年生存率为79%±10%。所有存活患者均处于纽约心脏协会心功能I级或II级。
我们得出以下结论:(1)主动脉根部扩张是马方综合征患儿最常见的手术指征;(2)二尖瓣反流是第二常见的指征;(3)主动脉夹层在马方综合征患儿中不常见;(4)需要仔细随访,尤其是对年幼患儿,因为超过一半的马方综合征患儿在10年内需要重复进行心脏手术。